Clinical Trial Update: Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial [NA]

View source ↗

Summary

The SphingoFIT trial update reports on a completed study evaluating whether reducing circulating sphingolipid levels can optimize cardiometabolic health in indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Dyslipidemias
• Hypertension
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: University of Basel | Conditions: Overweight and Obesity, Dyslipidemias | NA | Status: COMPLETED